Results 151 to 160 of about 675,878 (209)

Orthopaedic Surgery Outcomes in Patients With Haemophilia A or B Treated With Extended Half-Life Recombinant Factor VIII and IX Fc Fusion Proteins: A Multicentre Prospective Study. [PDF]

Haemophilia
Solimeno LP, Gualtierotti R, Guido E, Acquati Lozej J, Cristini E, Ciavarella A, Arcudi S, Carulli C, Pieri L, Siboni SM, Peyvandi F.   +10 more
europepmc   +1 more source

The APL-associated fusion proteins.

Haematologica, 1999
S. Minucci, M. Cioce, M. Maccarana, P. G. Pelicci   +3 more
openaire   +2 more sources

VGLL2 and TEAD1 fusion proteins identified in human sarcoma drive YAP/TAZ-independent tumorigenesis by engaging EP300. [PDF]

Elife
Guo S, Hu X, Cotton JL, Ma L, Li Q, Cui J, Wang Y, Thakare RP, Tao Z, Ip YT, Wu X, Wang J, Mao J.   +12 more
europepmc   +1 more source

Paratope mapping of tilvestamab, an anti-AXL function-blocking antibody, using high-throughput bacterial expression of secreted scFv-osmY fusion proteins. [PDF]

Biosci Rep
Christakou E, Kursula P, Micklem D.
europepmc   +1 more source

Induced degradation of SNAP-fusion proteins. [PDF]

RSC Chem Biol
Pol SA, Liljenberg S, Barr J, Simon G, Wong-Dilworth L, Paterson DL, Berishvili VP, Bottanelli F, Kaschani F, Kaiser M, Pettersson M, Hellerschmied D.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Therapeutic Fusion Proteins

The AAPS Journal, 2023
Therapeutic fusion proteins are a class of hybrid constructs that combine distinct biomolecules into a single platform with the additive effects of the components. The ability to fuse two unrelated proteins provides a means to localize mechanisms to better treat a range of diseases. Fusion proteins can be designed to impart diverse functions, including
Morgan C. Marsh, Shawn C. Owen
openaire   +4 more sources

Fusion proteins in biotechnology

Current Opinion in Biotechnology, 1992
Gene fusion techniques allow the production of recombinant proteins featuring the combined characteristics of the parental products. Originally, these techniques were used to probe transcriptional and translational activity, to translocate proteins across cell membranes, and to facilitate the recovery of proteins.
M, Uhlén, G, Forsberg, T, Moks, M, Hartmanis, B, Nilsson   +4 more
openaire   +2 more sources

An optimized antigen–protein fusion

Nature Biomedical Engineering, 2020
The fusion of an immunogenic peptide and the protein transthyretin protects the peptide antigen from proteolytic degradation, optimizes its uptake in local draining lymphatics and reduces its presentation in uninflamed distal lymphoid organs, as shown in mice.
Pedro Romero, Alena Donda, Jeffrey A. Hubbell   +2 more
openaire   +3 more sources

DEPLOYMENT OF MEMBRANE FUSION PROTEIN DOMAINS DURING FUSION

Cell Biology International, 2000
AbstractIt is clear that both viral and intracellular membrane fusion proteins contain a minimal set of domains which must be deployed at the appropriate time during the fusion process. An account of these domains and their functions is given here for the four best‐described fusion systems: influenza HA, sendai virus F1, HIV gp120/41 and the neuronal ...
J, Bentz, A, Mittal
openaire   +2 more sources

Preparation of GST Fusion Proteins

Cold Spring Harbor Protocols, 2007
INTRODUCTIONThis protocol describes the preparation of glutathione-S-transferase (GST) fusion proteins, which have had a wide range of applications since their introduction as tools for synthesis of recombinant proteins in bacteria. GST was originally selected as a fusion moiety because of several desirable properties.
Margret B, Einarson, Elena N, Pugacheva, Jason R, Orlinick   +2 more
openaire   +2 more sources